Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
902 studies found for:    Open Studies | "Carcinoma, Non-Small-Cell Lung"
Show Display Options
Rank Status Study
21 Recruiting A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Napabucasin;   Drug: Paclitaxel
22 Recruiting A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Atezolizumab;   Drug: Daratumumab
23 Not yet recruiting Neoantigen-primed Dendritic Cells (DC)- Pre-activated T (PreT) Cell Therapy for Refractory Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: T cells
24 Recruiting Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Durvalumab
25 Recruiting Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Apatinib;   Drug: Placebo
26 Recruiting MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MK-3475;   Drug: Gemcitabine
27 Recruiting Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Interventions: Genetic: Genomic profile by FoundationOne;   Genetic: Genomic profile by other methods
28 Recruiting Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cyclophosphamide;   Biological: DRibble vaccine;   Drug: Imiquimod;   Drug: GM-CSF;   Biological: HPV vaccine
29 Not yet recruiting A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Lorlatinib;   Drug: Crizotinib
30 Recruiting Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MPDL3280A;   Drug: Carboplatin;   Drug: Nab-paclitaxel
31 Recruiting Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: Radiation Therapy;   Radiation: Conventional radiation
32 Recruiting Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Radiation: Group 1: Peripherally Located Tumors;   Radiation: Group 2: Peripherally Located Chest Wall Adjacent Tumors;   Radiation: Group 3: Centrally Located Tumors
33 Recruiting Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
Condition: Non-small Cell Lung Cancer
Interventions: Other: clinical observation;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy
34 Recruiting A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: INC280 single agent;   Drug: INC280 in combination with erlotinib;   Drug: Platinum/pemetrexed
35 Recruiting Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers
Conditions: Carcinoma, Non-Small Cell Lung;   EGFR Gene Mutation
Intervention: Drug: Gemcitabine platinum combined with erlotinib
36 Recruiting Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction
Condition: Non-small Cell Lung Cancer
Intervention: Radiation: MR/PET
37 Recruiting Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Condition: Squamous Cell Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Abraxane (Induction);   Drug: Carboplatin (Induction);   Drug: Abraxane (Maintenance);   Other: Best Supportive Care (Maintenance)
38 Recruiting VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: treatment
39 Not yet recruiting A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: SHR-1210;   Drug: Apatinib
40 Recruiting Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: FKB238 (bevacizumab);   Drug: Avastin (bevacizumab);   Drug: Paclitaxel;   Drug: Carboplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.